ADAPT Data Linking Naproxen To Heart Risk Is “Not Reliable” – Nissen

The premature halting of the ADAPT trial and subsequent safety concerns for naproxen were "inappropriate and reflected faulty logic," according to Cleveland Clinic cardiologist Steven Nissen, MD